Biomarkers in Translational Medicine

Translational medicine is the emerging discipline involving the translation of laboratory findings into the design and implementation of early-stage clinical trials.TM focuses on translating pre-clinical data from in vivo, in vitro, and in silicon research into the clinic to help design trials, determine methods and choose the biomarkers. Biomarkers play a vital role in the development and growth of translational medicine. Predictive biomarkers are the markers which can be used to identify subpopulations of patients who are most likely to respond to a given therapy.

Biomarkers in clinical drug development enable continued clinical development of drugs suspected of human irrelevant animal toxicities– ensuring patient safety, reducing drug failures and loss of time. A genomic biomarker is a measurable DNA or RNA characteristic that is an indicator of normal biologic processes, pathology diagnosis and response to therapeutic or other interventions. Ex: Cancer Biomarker Specific and sensitive mRNA biomarkers are used for the identification of skin in ‘touch DNA’ evidence.

Traditionally, oncology has been at the forefront of the biomarker development and PM. However, as technologies advance, fields such as neuroscience and immunological, inflammatory, and metabolic diseases are expanding their use of biomarkers for PM. Translational medicine seeks to identify individuals who will receive the most clinical benefit and least harm from a specific treatment by targeting genetic or other targets associated with their disease. Enabled by technological advances and expansion of the use of biomarkers, researchers can stratify patients into disease subtypes and evaluate targeted therapies aimed at treating them.

Translational medicine is the emerging discipline involving the translation of laboratory findings into the design and implementation of early-stage clinical trials.TM focuses on translating pre-clinical data from in vivo, in vitro, and in silicon research into the clinic to help design trials, determine methods and choose the biomarkers. Biomarkers play a vital role in the development and growth of translational medicine. Predictive biomarkers are the markers which can be used to identify subpopulations of patients who are most likely to respond to a given therapy.

  • Biomarker discovery
  • Clinical validation of predictive biomarkers
  • Role of biomarkers in clinical drug development
  • Integrating genomic biomarkers into clinical development
  • mRNA biomarkers

Related Conference of Biomarkers in Translational Medicine

October 18-20, 2017

10th World Congress on Biomarkers & Clinical Research

Baltimore, USA
November 13-15,2017

17th World Fitness Expo

(10 Plenary Forums - 1Event) Atlanta, USA
December 07-08, 2017

29th World Psychiatrists Meet

Dubai, UAE
March 22-24, 2018

Annual Physicians Meeting 2018

Dubai, UAE
April 16-17, 2018

World Congress on Gynecology and Obstetrics

April 16-17, 2018
April 23-24, 2018

International Conference on Internal Medicine

Dubai, UAE
June 21-22, 2018

3rd International Conference on Anesthesia

Dublin, Ireland
September 24-25, 2018

9th International Conference on Clinical & Medical Case Reports

| Amsterdam, Netherlands
October 15-16, 2018

Annual congress on Research and Innovations in Medicine

Seoul, South Korea
November 27-28, 2018

World Summit on Psychiatry and Mental Health Nursing

Los Angeles, USA

Biomarkers in Translational Medicine Conference Speakers

Recommended Sessions

Related Journals

Are you interested in